{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:00:48Z","timestamp":1793826048975,"version":"4.6.1"},"reference-count":39,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,10,1]]},"DOI":"10.5551\/jat.65654","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T18:06:16Z","timestamp":1744481176000},"page":"1251-1267","source":"Crossref","is-referenced-by-count":18,"title":["The Incremental Prognostic Value of Incorporating the Triglyceride-Glucose Index into the Traditional Cardiovascular Risk Factors for the Long-term Prognosis in Ischemic Cardiomyopathy Patients with HFpEF following Coronary Artery Bypass Grafting: A Multicenter Cohort Study"],"prefix":"10.5551","volume":"32","author":[{"given":"Huaiyu","family":"Ruan","sequence":"first","affiliation":[{"name":"Department of Cardiology; The First Affiliated Hospital of Bengbu Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoupeng","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"He","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Zhujiang Hospital, Southern Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Wang","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoya","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Cardiology; The First Affiliated Hospital of Bengbu Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Bengbu Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Yin","sequence":"additional","affiliation":[{"name":"People's Hospital of Xinjiang Uygur Autonomous Region, Electrocardiology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Xinjiang Medical University"},{"name":"Department of Cardiology Fourth Ward, The Xinjiang Medical University Affiliated Hospital of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology; The First Affiliated Hospital of Bengbu Medical University"},{"name":"Joint Research Center for Regional Diseases of IHM,Bengbu Medical University"},{"name":"Joint Research Center for Regional Diseases of IHM, The First Affiliated Hospital of Bengbu Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology; The First Affiliated Hospital of Bengbu Medical University"},{"name":"Joint Research Center for Regional Diseases of IHM,Bengbu Medical University"},{"name":"Joint Research Center for Regional Diseases of IHM, The First Affiliated Hospital of Bengbu Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Stefan N, Schulze MB. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol, 2023; 11: 426-440","DOI":"10.1016\/S2213-8587(23)00086-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Li Q, Wang P, Ma R, Guo X, Sun Y, Zhang X. A novel criterion of metabolically healthy obesity could effectively identify individuals with low cardiovascular risk among Chinese cohort. Front Endocrinol (Lausanne), 2023; 26; 14: 1140472","DOI":"10.3389\/fendo.2023.1140472"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Petersen MC, Smith GI, Palacios HH, Farabi SS, Yoshino M, Yoshino J, Cho K, Davila-Roman VG, Shankaran M, Barve RA, Yu J, Stern JH, Patterson BW, Hellerstein MK, Shulman GI, Patti GJ, Klein S. Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity. Cell Metab, 2024, 2; 36: 745-761.e5","DOI":"10.1016\/j.cmet.2024.03.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Zembic A, Eckel N, Stefan N, Baudry J, Schulze MB. An Empirically Derived Definition of Metabolically Healthy Obesity Based on Risk of Cardiovascular and Total Mortality. JAMA Netw Open, 2021, 3; 4: e218505","DOI":"10.1001\/jamanetworkopen.2021.8505"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Valenzuela PL, Carrera-Bastos P, Castillo-Garc\u00eda A, Lieberman DE, Santos-Lozano A, Lucia A. Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol, 2023 ; 20: 475-494","DOI":"10.1038\/s41569-023-00847-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Saxon DR, Reiter-Brennan C, Blaha MJ, Eckel RH. Cardiometabolic Medicine: Development of a New Subspecialty. J Clin Endocrinol Metab, 2020,1; 105: dgaa261","DOI":"10.1210\/clinem\/dgaa261"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism, 2021 ; 119: 154766","DOI":"10.1016\/j.metabol.2021.154766"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, Jacques-Camarena O, Rodr\u00edguez-Mor\u00e1n M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab, 2010; 95: 3347-3351","DOI":"10.1210\/jc.2010-0288"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, Tambascia MA, Saad MJ, Geloneze B. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract, 2011; 93: e98-e100","DOI":"10.1016\/j.diabres.2011.05.030"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol, 2022, 6; 21: 68","DOI":"10.1186\/s12933-022-01511-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Abuduaini B, Yang L, Jiamali N, Seyiti Z, Shan XF, Gao XM. Predictive Effect of Triglyceride-Glucose Index on Adverse Prognostic Events in Patients with Type 2 Diabetes Mellitus and Ischemic Cardiomyopathy. Diabetes Metab Syndr Obes, 2023, 20; 16: 1093-1107","DOI":"10.2147\/DMSO.S408766"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Zhou Y, Wang C, Che H, Cheng L, Zhu D, Rao C, Zhong Q, Li Z, Wang X, Wu Z, He K. Association between the triglyceride-glucose index and the risk of mortality among patients with chronic heart failure: results from a retrospective cohort study in China. Cardiovasc Diabetol, 2023,7; 22: 171","DOI":"10.1186\/s12933-023-01978-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) 13]Zhou Q, Yang J, Tang H, Guo Z, Dong W, Wang Y, Meng X, Zhang K, Wang W, Shao C, Hua X, Tang YD. High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction. Cardiovasc Diabetol, 2023,29; 22: 263","DOI":"10.1186\/s12933-023-02001-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Campbell P, Rutten FH, Lee MM, Hawkins NM, Petrie MC. Heart failure with preserved ejection fraction: everything the clinician needs to know. Lancet, 2024, 16; 403: 1083-1092","DOI":"10.1016\/S0140-6736(23)02756-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Redfield MM, Borlaug BA. Heart Failure With Preserved Ejection Fraction: A Review. JAMA, 2023,14; 329(10): 827-838","DOI":"10.1001\/jama.2023.2020"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Wang J, Wang Y, Duan S, Xu L, Xu Y, Yin W, Yang Y, Wu B, Liu J. Multimodal Data-Driven Prognostic Model for Predicting Long-Term Prognosis in Patients With Ischemic Cardiomyopathy and Heart Failure With Preserved Ejection Fraction After Coronary Artery Bypass Grafting: A Multicenter Cohort Study. J Am Heart Assoc, 2024,3; 13: e036970","DOI":"10.1161\/JAHA.124.036970"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sinha A, Rahman H, Webb A, Shah AM, Perera D. Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction. Eur Heart J, 2021,14; 42: 4431-4441","DOI":"10.1093\/eurheartj\/ehab653"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA, 2003,20; 290: 898-904","DOI":"10.1001\/jama.290.7.898"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Authors\/Task Force Members: ; McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK; ESC Scientific Document Group. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail, 2024; 26: 5-17","DOI":"10.1002\/ejhf.3024"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Wu Z, Xie L, Guo D, Chen S, Liu X, Sun X, Wang J, Zhang Y, Liu L, Cui H, Zang D, Yang J. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients without diabetes mellitus after coronary artery bypass grafting: a multicenter retrospective cohort study. Cardiovasc Diabetol, 2023,30; 22: 230","DOI":"10.1186\/s12933-023-01969-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Zhang Y, Zhang C, Jiang L, Xu L, Tian J, Zhao X, Wang D, Zhang Y, Sun K, Zhang C, Xu B, Zhao W, Hui R, Gao R, Wang J, Feng X, Yuan J, Song L. An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease. Cardiovasc Diabetol, 2023,6; 22: 333","DOI":"10.1186\/s12933-023-02063-4"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord, 2008; 6: 299-304","DOI":"10.1089\/met.2008.0034"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab, 2008,294: E15-26","DOI":"10.1152\/ajpendo.00645.2007"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Mohd Nor NS, Lee S, Bacha F, Tfayli H, Arslanian S. Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatr Diabetes, 2016 Sep; 17: 458-465","DOI":"10.1111\/pedi.12303"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, Xu B. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol, 2023, 30; 22: 75","DOI":"10.1186\/s12933-023-01794-8"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Shi W, Qin M, Wu S, Xu K, Zheng Q, Liu X. Usefulness of Triglyceride-glucose index for detecting prevalent atrial fibrillation in a type 2 diabetic population. Postgrad Med, 2022; 134(8): 820-828","DOI":"10.1080\/00325481.2022.2124088"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Xu Z, Chen P, Wang L, Yan J, Yan X, Li D. Relationship between TyG index and the degree of coronary artery lesions in patients with H-type hypertension. Cardiovasc Diabetol, 2024,12; 23: 23","DOI":"10.1186\/s12933-023-02013-0"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Zhou T, Wang Y, Xu Y, Xu L, Tang L, Yang Y, Wang J. Multimodal data integration for enhanced longitudinal prediction for cardiac and cerebrovascular events following initial diagnosis of obstructive sleep apnea syndrome. J Glob Health, 2024, 17; 14: 04103","DOI":"10.7189\/jgh.14.04103"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ye Z, Xu Y, Tang L, Wu M, Wu B, Zhu T, Wang J. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model. Cardiovasc Diabetol, 2023,13; 22: 87","DOI":"10.1186\/s12933-023-01820-9"},{"key":"#cr-split#-30.1","doi-asserted-by":"crossref","unstructured":"30) Xu Y, Wang J, Zhou Z, Yang Y, Tang L. Multimodal Prognostic Model for Predicting Chronic Coronary Artery Disease in Patients Without Obstructive Sleep Apnea Syndrome. Arch Med Res, 2024","DOI":"10.1016\/j.arcmed.2023.102926"},{"key":"#cr-split#-30.2","unstructured":"55: 102926.[J]. Arch Med Res, 2024,1: 102926"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Chen Q, Xiong S, Ye T, Gao Y, Wang J, Li X, Li Y, Cui C, Liu H, Zhang Z, Cai L, Zheng J. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome. Cardiovasc Diabetol, 2024,16; 23: 172","DOI":"10.1186\/s12933-024-02276-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Lin Z, He J, Song C, Yuan S, Song Y, Bian X, Dou K. Association of triglyceride-glucose index with adverse cardiovascular events in patients with established coronary artery disease according to different inflammatory status. Nutr Metab Cardiovasc Dis, 2024; 34: 2124-2133","DOI":"10.1016\/j.numecd.2024.04.010"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Sun Q, Karwi QG, Wong N, Lopaschuk GD. Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond. Cardiovasc Res, 2024, 14; 120: 1996-2016","DOI":"10.1093\/cvr\/cvae231"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Noordali H, Loudon BL, Frenneaux MP, Madhani M. Cardiac metabolism - A promising therapeutic target for heart failure. Pharmacol Ther, 2018; 182: 95-114","DOI":"10.1016\/j.pharmthera.2017.08.001"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Salah K, Stienen S, Pinto YM, Eurlings LW, Metra M, Bayes-Genis A, Verdiani V, Tijssen JGP, Kok WE. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction. Heart, 2019; 105: 1182-1189","DOI":"10.1136\/heartjnl-2018-314173"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Ni W, Jiang R, Xu D, Zhu J, Chen J, Lin Y, Zhou H. Association between insulin resistance indices and outcomes in patients with heart failure with preserved ejection fraction. Cardiovasc Diabetol, 2025,22; 24: 32","DOI":"10.1186\/s12933-025-02595-x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Bays HE, Kulkarni A, German C, Satish P, Iluyomade A, Dudum R, Thakkar A, Rifai MA, Mehta A, Thobani A, Al-Saiegh Y, Nelson AJ, Sheth S, Toth PP. Ten things to know about ten cardiovascular disease risk factors - 2022. Am J Prev Cardiol, 2022,6; 10: 100342","DOI":"10.1016\/j.ajpc.2022.100342"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Tan W, Wang Y, Cheng S, Liu Z, Xie M, Song L, Qiu Q, Wang X, Li Z, Liu T, Guo F, Wang J, Zhou X. AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis. J Adv Res, 2025; 68: 299-315","DOI":"10.1016\/j.jare.2024.02.015"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/10\/32_65654\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:36:18Z","timestamp":1759552578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/10\/32_65654\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65654","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"65654"}}